429 related articles for article (PubMed ID: 24234650)
21. Genetic polymorphisms in LDLR, APOB, PCSK9 and other lipid related genes associated with familial hypercholesterolemia in Malaysia.
Lye SH; Chahil JK; Bagali P; Alex L; Vadivelu J; Ahmad WA; Chan SP; Thong MK; Zain SM; Mohamed R
PLoS One; 2013; 8(4):e60729. PubMed ID: 23593297
[TBL] [Abstract][Full Text] [Related]
22. Leucine 10 allelic variant in signal peptide of PCSK9 increases the LDL cholesterol-lowering effect of statins in patients with familial hypercholesterolaemia.
Pisciotta L; Sallo R; Rabacchi C; Wunsch A; Calandra S; Bertolini S
Nutr Metab Cardiovasc Dis; 2012 Oct; 22(10):831-5. PubMed ID: 21920719
[TBL] [Abstract][Full Text] [Related]
23. LDLR promoter variant and exon 14 mutation on the same chromosome are associated with an unusually severe FH phenotype and treatment resistance.
Snozek CL; Lagerstedt SA; Khoo TK; Rubenfire M; Isley WL; Train LJ; Baudhuin LM
Eur J Hum Genet; 2009 Jan; 17(1):85-90. PubMed ID: 18648394
[TBL] [Abstract][Full Text] [Related]
24. Genetic defects causing familial hypercholesterolaemia: identification of deletions and duplications in the LDL-receptor gene and summary of all mutations found in patients attending the Hammersmith Hospital Lipid Clinic.
Tosi I; Toledo-Leiva P; Neuwirth C; Naoumova RP; Soutar AK
Atherosclerosis; 2007 Sep; 194(1):102-11. PubMed ID: 17094996
[TBL] [Abstract][Full Text] [Related]
25. Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales.
Haralambos K; Whatley SD; Edwards R; Gingell R; Townsend D; Ashfield-Watt P; Lansberg P; Datta DB; McDowell IF
Atherosclerosis; 2015 May; 240(1):190-6. PubMed ID: 25797312
[TBL] [Abstract][Full Text] [Related]
26. Use of targeted exome sequencing as a diagnostic tool for Familial Hypercholesterolaemia.
Futema M; Plagnol V; Whittall RA; Neil HA; ; Humphries SE;
J Med Genet; 2012 Oct; 49(10):644-9. PubMed ID: 23054246
[TBL] [Abstract][Full Text] [Related]
27. PCSK9 R46L, lower LDL, and cardiovascular disease risk in familial hypercholesterolemia: a cross-sectional cohort study.
Saavedra YG; Dufour R; Davignon J; Baass A
Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2700-5. PubMed ID: 25278291
[TBL] [Abstract][Full Text] [Related]
28. Genetic diagnosis of familial hypercholesterolaemia by targeted next-generation sequencing.
Maglio C; Mancina RM; Motta BM; Stef M; Pirazzi C; Palacios L; Askaryar N; Borén J; Wiklund O; Romeo S
J Intern Med; 2014 Oct; 276(4):396-403. PubMed ID: 24785115
[TBL] [Abstract][Full Text] [Related]
29. Common mutations of familial hypercholesterolemia patients in Taiwan: characteristics and implications of migrations from southeast China.
Chiou KR; Charng MJ
Gene; 2012 Apr; 498(1):100-6. PubMed ID: 22353362
[TBL] [Abstract][Full Text] [Related]
30. Genetic variation in APOB, PCSK9, and ANGPTL3 in carriers of pathogenic autosomal dominant hypercholesterolemic mutations with unexpected low LDL-Cl Levels.
Huijgen R; Sjouke B; Vis K; de Randamie JS; Defesche JC; Kastelein JJ; Hovingh GK; Fouchier SW
Hum Mutat; 2012 Feb; 33(2):448-55. PubMed ID: 22095935
[TBL] [Abstract][Full Text] [Related]
31. Genetic heterogeneity of autosomal dominant hypercholesterolemia in Mexico.
Robles-Osorio L; Huerta-Zepeda A; Ordóñez ML; Canizales-Quinteros S; Díaz-Villaseñor A; Gutiérrez-Aguilar R; Riba L; Huertas-Vázquez A; Rodríguez-Torres M; Gómez-Díaz RA; Salinas S; Ongay-Larios L; Codiz-Huerta G; Mora-Cabrera M; Mehta R; Gómez Pérez FJ; Rull JA; Rabès JP; Tusié-Luna MT; Durán-Vargas S; Aguilar-Salinas CA
Arch Med Res; 2006 Jan; 37(1):102-8. PubMed ID: 16314194
[TBL] [Abstract][Full Text] [Related]
32. Detection of mutations and large rearrangements of the low-density lipoprotein receptor gene in Taiwanese patients with familial hypercholesterolemia.
Chiou KR; Charng MJ
Am J Cardiol; 2010 Jun; 105(12):1752-8. PubMed ID: 20538126
[TBL] [Abstract][Full Text] [Related]
33. The molecular basis of familial hypercholesterolemia in Lebanon: spectrum of LDLR mutations and role of PCSK9 as a modifier gene.
Abifadel M; Rabès JP; Jambart S; Halaby G; Gannagé-Yared MH; Sarkis A; Beaino G; Varret M; Salem N; Corbani S; Aydénian H; Junien C; Munnich A; Boileau C
Hum Mutat; 2009 Jul; 30(7):E682-91. PubMed ID: 19319977
[TBL] [Abstract][Full Text] [Related]
34. The molecular basis of familial hypercholesterolemia in the Czech Republic: spectrum of LDLR mutations and genotype-phenotype correlations.
Tichý L; Freiberger T; Zapletalová P; Soška V; Ravčuková B; Fajkusová L
Atherosclerosis; 2012 Aug; 223(2):401-8. PubMed ID: 22698793
[TBL] [Abstract][Full Text] [Related]
35. Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countries.
Futema M; Shah S; Cooper JA; Li K; Whittall RA; Sharifi M; Goldberg O; Drogari E; Mollaki V; Wiegman A; Defesche J; D'Agostino MN; D'Angelo A; Rubba P; Fortunato G; Waluś-Miarka M; Hegele RA; Aderayo Bamimore M; Durst R; Leitersdorf E; Mulder MT; Roeters van Lennep JE; Sijbrands EJ; Whittaker JC; Talmud PJ; Humphries SE
Clin Chem; 2015 Jan; 61(1):231-8. PubMed ID: 25414277
[TBL] [Abstract][Full Text] [Related]
36. [Familial hypercholesterolemia in Tunisia].
Jelassi A; Jguirim I; Najah M; Maatouk F; Ben Hamda K; Slimane MN
Pathol Biol (Paris); 2009 Jul; 57(5):444-50. PubMed ID: 19041195
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the frequency and spectrum of mutations recognised to cause familial hypercholesterolaemia in routine clinical practice in a UK specialist hospital lipid clinic.
Futema M; Whittall RA; Kiley A; Steel LK; Cooper JA; Badmus E; Leigh SE; Karpe F; Neil HA; ; Humphries SE
Atherosclerosis; 2013 Jul; 229(1):161-8. PubMed ID: 23669246
[TBL] [Abstract][Full Text] [Related]
38. Reduced penetrance of autosomal dominant hypercholesterolemia in a high percentage of families: importance of genetic testing in the entire family.
Garcia-Garcia AB; Ivorra C; Martinez-Hervas S; Blesa S; Fuentes MJ; Puig O; Martín-de-Llano JJ; Carmena R; Real JT; Chaves FJ
Atherosclerosis; 2011 Oct; 218(2):423-30. PubMed ID: 21868016
[TBL] [Abstract][Full Text] [Related]
39. Spectrum of LDLR gene mutations, including a novel mutation causing familial hypercholesterolaemia, in North-western Greece.
Diakou M; Miltiadous G; Xenophontos SL; Manoli P; Cariolou MA; Elisaf M
Eur J Intern Med; 2011 Oct; 22(5):e55-9. PubMed ID: 21925044
[TBL] [Abstract][Full Text] [Related]
40. A novel type of familial hypercholesterolemia: double heterozygous mutations in LDL receptor and LDL receptor adaptor protein 1 gene.
Tada H; Kawashiri MA; Ohtani R; Noguchi T; Nakanishi C; Konno T; Hayashi K; Nohara A; Inazu A; Kobayashi J; Mabuchi H; Yamagishi M
Atherosclerosis; 2011 Dec; 219(2):663-6. PubMed ID: 21872251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]